Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/18/26 17:00 | 8/17/26 | VRCA | Health | Drug | Pharmaceutical Preparations | Zawitz David | PA | O | COO | 2 | P.d | 72 | 4.52 | 0 | 16 | 145 | 27 | D | ||||||||||||||
8/18/26 17:00 | 8/17/26 | VRCA | Health | Drug | Pharmaceutical Preparations | Rosenberg Noah L. | PA | O | CMO | 2 | P.dm | 41 | 4.73 | 0 | 9 | 9 | D | |||||||||||||||
8/18/26 17:00 | 8/14/26 | VRCA | Health | Drug | Pharmaceutical Preparations | Rieger Jayson | PA | DO | CEO,P | 2 | P.dm | 526 | 4.41 | 0 | 119 | 134 | 208 | D | ||||||||||||||
8/18/26 17:00 | 8/18/26 | VRCA | Health | Drug | Pharmaceutical Preparations | Kirby John J. | PA | O | Interim | 2 | P.d | 40 | 4.65 | 0 | 9 | 55 | 24 | D | ||||||||||||||
11/25/25 19:00 | 11/25/25 | VRCA | Health | Drug | Pharmaceutical Preparations | Manning Paul B | VA | DT | 1 | P.d | 17,505 | 4.24 | 0 | 4,126 | 108 | 7,932 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |